Prior reports have noted ISG15 upregulation in models of focal and global cerebral ischemia, CNS viral infection, TBI associated ALS, ataxia-telangiectasia, and to a limited extent in viral and toxic models of demyelinating disease [39, 40, 47, 151–156]. This evidence concerns the gene ISG15 and demyelinating disease.